长轴视野PET/CT在高血糖患者中的FDG显像:匹配配对分析
本研究将31例血糖≥8.0 mmol/l的肿瘤患者与31例血糖<8.0 mmol/l患者按肿瘤类型、性别、年龄和BMI匹配,比较长轴视野(LAFOV)PET/CT与模拟短轴视野(sSAFOV)PET/CT的图像质量。高血糖组肝脏摄取更高、脑摄取更低,肿瘤与本底比值(TBR)和对比噪声比(CNR)更低;但血糖8-11 mmol/l患者sSAFOV与血糖>11 mmol/l患者LAFOV的CNR无统计学显著差异。作者认为当无法重新预约时,高血糖肿瘤患者可安全接受LAFOV PET/CT显像。
要点
- 高血糖组肝脏SUVmean 3.07±0.41高于正常血糖组2.37±0.33,脑SUVmax 7.58±0.74低于13.38±3.94。
- 高血糖组TBR 3.48±0.74低于正常血糖组5.29±1.48,CNR 12.17±4.86低于23.31±12.22。
- 血糖8-11 mmol/l组sSAFOV与血糖>11 mmol/l组LAFOV的CNR 19.84±8.40 vs 17.79±9.3无统计学显著差异(p=0.08)。
核心结论
- 血糖升高(>11 mmol/l)对TBR和CNR有负面影响,但LAFOV PET/CT图像的CNR与正常血糖患者sSAFOV PET/CT图像相当。
- 作者认为当无法重新预约时,血糖升高的肿瘤患者可安全接受LAFOV PET/CT显像。
研究设计与样本
- 研究为匹配配对分析,纳入肿瘤患者,高血糖组(血糖≥8.0 mmol/l)31例与正常血糖组(血糖<8.0 mmol/l)31例按肿瘤类型、性别、年龄和BMI匹配。
- 高血糖组进一步分为血糖8-11 mmol/l和血糖>11 mmol/l两个亚组。
- 比较LAFOV PET/CT长采集(超高灵敏度模式,360秒)与模拟短轴视野PET/CT(sSAFOV,高灵敏度模式,120秒)的图像质量。
主要发现
- 高血糖组肝脏摄取显著高于正常血糖组(SUVmean 3.07±0.41 vs 2.37±0.33,p=0.03)。
- 高血糖组脑摄取显著低于正常血糖组(SUVmax 7.58±0.74 vs 13.38±3.94,p<0.001)。
- 肌肉(肩部/臀部)摄取在两组间无统计学显著差异。
- 高血糖组肿瘤摄取较低,导致TBR显著低于正常血糖组(3.48±0.74 vs 5.29±1.48,p<0.001)。
- 正常血糖组CNR高于高血糖组(23.31±12.22 vs 12.17±4.86,p<0.001)。
关键数值与推荐
- 高血糖定义为血糖≥8.0 mmol/l,正常血糖定义为血糖<8.0 mmol/l。
- 高血糖亚组分为血糖8-11 mmol/l和血糖>11 mmol/l。
- 图像质量主要评价指标为肿瘤与本底比值(TBR)和对比噪声比(CNR)。
临床怎么用
- 作者认为当无法重新预约时,血糖升高的肿瘤患者可安全接受LAFOV PET/CT显像。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: High blood glucose (hBG) in patients undergoing [18F]FDG PET/CT scans often results in rescheduling the examination, which may lead to clinical delay for the patient and decrease productivity for the department. The aim of this study was to evaluate whether long-axial field-of-view (LAFOV) PET/CT can minimize the effect of altered bio-distribution in hBG patients and is able to provide diagnostic image quality in hBG situations. MATERIALS AND METHODS: Oncologic patients with elevated blood glucose (≥ 8.0 mmol/l) and normal blood glucose (< 8.0 mmol/l, nBG) levels were matched for tumor entity, gender, age, and BMI. hBG patients were further subdivided into two groups (BG 8-11 mmol/l and BG > 11 mmol/l). Tracer uptake in the liver, muscle, and tumor was evaluated. Furthermore, image quality was compared between long acquisitions (ultra-high sensitivity mode, 360 s) on a LAFOV PET/CT and routine acquisitions equivalent to a short-axial field-of-view scanner (simulated (sSAFOV), obtained with high sensitivity mode, 120 s). Tumor-to-background ratio (TBR) and contrast-to-noise ratio (CNR) were used as the main image quality criteria. RESULTS: Thirty-one hBG patients met the inclusion criteria and were matched with 31 nBG patients. Overall, liver uptake was significantly higher in hBG patients (SUVmean, 3.07 ± 0.41 vs. 2.37 ± 0.33; p = 0.03), and brain uptake was significantly lower (SUVmax, 7.58 ± 0.74 vs. 13.38 ± 3.94; p < 0.001), whereas muscle (shoulder/gluteal) uptake showed no statistically significant difference. Tumor uptake was lower in hBG patients, resulting in a significantly lower TBR in the hBG cohort (3.48 ± 0.74 vs. 5.29 ± 1.48, p < 0.001). CNR was higher in nBG compared to hBG patients (12.17 ± 4.86 vs. 23.31 ± 12.22, p < 0.001). However, subgroup analysis of nBG 8-11 mmol/l on sSAFOV PET/CT compared to hBG (> 11 mmol/l) patients examined with LAFOV PET/CT showed no statistical significant difference in CNR (19.84 ± 8.40 vs. 17.79 ± 9.3, p = 0.08). CONCLUSION: While elevated blood glucose (> 11 mmol) negatively affected TBR and CNR in our cohort, the images from a LAFOV PET-scanner had comparable CNR to PET-images acquired from nBG patients using sSAFOV PET/CT. Therefore, we argue that oncologic patients with increased blood sugar levels might be imaged safely with LAFOV PET/CT when rescheduling is not feasible.
引用
- Mingels C, Weissenrieder L, Zeimpekis K, et al. FDG imaging with long-axial field-of-view PET/CT in patients with high blood glucose-a matched pair analysis. Eur J Nucl Med Mol Imaging. 2024. PMID: 38383743. doi:10.1007/s00259-024-06646-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。